Health, Food, and Drug Law

Mason Marks, POPLAR project lead and Petrie-Flom senior fellow, explains how the initiative will fill a gap in research on the ethical, legal, and social implications of psychedelics law and policy, and previews some of the initiative’s topics of inquiry.

Health law has become especially timely in this year of COVID-19 vaccines and revitalized Obamacare. But for graduating student Phebe Hong ’21, it’s a passion that began in high school.

Zachary Weinstein ’21 didn’t always want to be a lawyer. In fact, for most of his life, he was more likely to be found in front of a camera than in front of a judge.

Emily M. Broad Leib ’08, faculty director of the Food Law and Policy Clinic, discusses food insecurity and the challenges and crises in the U.S. food system, which have been exacerbated by the COVID-19 pandemic.

The Last Lecture Series at Harvard Law School, sponsored annually by the 3L and LL.M. class marshals, is an HLS tradition in which selected faculty members impart insight, advice, and final words of wisdom to the graduating class.

In evaluating President Biden's first 100 days, Harvard Law Professor Elizabeth Bartholet says the president has been a champion for children and families, but she hopes he will also reform the current homeschooling regime .

I. Glenn Cohen ’03 and Carmel Shachar J.D./M.P.H. ’10 of the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics discuss the Biden administration's healthcare agenda.

What are the ramifications of this pandemic year for medical practitioners? And how might the future of health care be shaped by the wounds inflicted on those we entrust with our lives?

The effect of COVID-19 on the law has been transformative and wide-ranging, but as a Harvard Law School panel pointed out on the one-year anniversary of campus shutdown, the changes haven’t all been for the worse.

Disheartened by tales from family and friends frustrated by his home state of Pennsylvania's vaccine distribution system, Seth Rubinstein ’22, a second year student at Harvard Law School, knew he wanted to get involved.

Harvard Law alum Daniel Aaron ’20 thinks high obesity rates among people of color may be another legacy of ongoing racism in America.

Since President Joe Biden took office in January, dozens of Harvard Law community members, including faculty and alumni, have been tapped to serve in high-profile positions in his administration

On February 11, the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School announced the formation of its new advisory board.

Should smoking be among the pre-existing health risks that qualify people for priority access to the COVID-19 vaccine? Harvard Law public health expert Carmel Shachar says the answer is yes. 

In their new report, An Evaluation of the Farmers to Families Food Box Program, Harvard's Food Law and Policy Clinic and the National Sustainable Agriculture Coalition highlight opportunities to make the program more equitable and effective amid the COVID-19 pandemic and beyond.

The Petrie-Flom Center at Harvard Law School is joining forces with the Solomon Center for Health Law and Policy, its counterpart at Yale Law School, to host a seminar series reflecting on ethical and legal issues raised by the COVID-19 pandemic.

Public health expert Carmel Shachar discusses the COVID-19 vaccine, who is likely to get it first, and whether people can be required to get vaccinated.

Experts gathered this week to discuss the ethical, social, and legal implications of technological advancements that facilitate the early detection of dementia.

HLS faculty on COVID-19 and the pressing questions of racism, racial injustice, and abuse of power that have driven this difficult year—and that are the focus of three new lecture series at the school.

Cass Sunstein ’78, Robert Walmsley University Professor and former Administrator of the White House Office of Information and Regulatory Affairs in the Obama administration, believes “Nudge theory” might help bridge the gap between supply and demand for organ transplants.

In an interview with Harvard Law Today, Carmel Shachar, executive director of the Petrie-Flom Center for Health Policy, Biotechnology, and Bioethics at Harvard Law School, says that political interference in the FDA’s process for ensuring that a vaccine is both safe and effective “opens the door to a public health disaster.”